MedTrace Logo

The Effect of Phentermine and B12 on Weight Loss Among Obese Patients

NCT01719185 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2015-08-13

No results posted yet for this study

Summary

This is a pilot study designed to test the hypothesis that the combination of phentermine and B12 will result in significantly greater weight loss among obese patients compared to phentermine alone.

Conditions

Interventions

DRUG

Phentermine and B12

DRUG

Phentermine

Sponsors & Collaborators

  • Dr. Michael Lang

    lead OTHER

Principal Investigators

  • Michael C Lang, MD · ECU Physicians General Internal Medicine, Psychiatry

  • James Powell, MD · ECU Physicians General Internal Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2013-01-31
Completion
2013-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01719185 on ClinicalTrials.gov